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Mutations in the human cytomegalovirus UL27 gene confer resistance to an inhibitor of the viral protein
kinase UL97. Reitsma and colleagues (2011) demonstrate that UL27 destabilizes the Tip60 histone acetyl-
transferase, setting forth intriguing new mechanisms for antiviral drug resistance and for viral regulation of
the cell cycle.Well before the term chemical biology
became popular, much was learned
about the biology and biochemistry of
viruses from studying small-molecule
antiviral drugs and mutants resistant to
them. These discoveries included the
finding that the influenza virus M2 protein
forms an ion channel from studies of
amantadine-resistant mutant viruses and
the finding that the human cytomegalo-
virus (HCMV) UL97 (or pUL97) protein
kinase can phosphorylate nucleoside
analogs from studies of ganciclovir-resis-
tant mutant viruses. But UL97 is important
for more than phosphorylating antiviral
drugs. A major physiologic role of UL97
is to act as a viral mimic of cyclin-depen-
dent kinase complexes (CDKs). HCMV
ordinarily arrests the cell cycle of produc-
tively infected cells at the G1/S boundary.
Upon infection of quiescent cells, UL97
phosphorylates retinoblastoma tumor
suppressor (Rb) family pocket proteins,
which in turn results in expression of S
phase genes that likely are crucial for
HCMV DNA synthesis (Hume et al.,
2008; Kamil et al., 2009).
An inhibitor of UL97 kinase activity,
maribavir, has antiviral activity in cell
culture and showed promise as an anti-
viral drug in humans in phase I and
phase II clinical trials. As with other
antiviral agents, drug-resistant viruses
emerge during serial passage of HCMV
in the presence ofmaribavir. As expected,
many of these viruses contain mutations
in the UL97 open reading frame (ORF)
that confer high-level resistance to mari-
bavir. However, others of these viruses
contain mutations in the UL27 ORF that
confer modest resistance to maribavir
(Komazin et al., 2003). This observationis highly unusual, as nearly all virus drug
resistance mutations directly alter drug
targets. TheUL27ORF encodes a nuclear
protein, UL27 (or pUL27). There have
been precious few clues, if any, as to the
function of UL27. The murine CMV
(MCMV) UL27 homolog, M27, is respon-
sible for degradation of STAT2, which
provides a mechanism for viral interfer-
ence with a/b IFN receptor signaling and
evasion of innate immunity. However,
degradation of STAT2 occurs in a UL27-
independent manner in HCMV-infected
cells (Le et al., 2008).
To investigate the function of UL27,
Reitsma et al. (2011) used mass spec-
trometry to detect proteins from infected
cells that copurified with epitope-tagged
UL27 expressed from an engineered
HCMV. This was not an easy experiment,
as UL27 is not abundant. Among the
putative UL27 interaction partners they
detected were five members of the
Tip60 histone acetyltransferase (HAT)
core complex, yet not Tip60 itself. None-
theless, the authors examined Tip60
expression during HCMV infection and
observed that Tip60 undergoes rapid,
proteasome-dependent degradation dur-
ing the early phase of HCMV infection
and that UL27 is necessary and sufficient
for this effect. Viruses lacking UL27
expression were unable to cause Tip60
degradation and, in the presence of mar-
ibavir, consistent with previous studies,
were able to replicate to higher yield and
synthesize higher levels of viral DNA
than wild-type HCMV.
Tip60, a MYST family HAT, was first
identified by virtue of its interaction with
HIV-1 Tat (Kamine et al., 1996). Later,
Tip60was shown tobepart of amultimericCell Host & Microbe 9complex with DNA helicase, ATPase,
and DNA binding properties and to
play roles in a wide array of cellular
processes, including transcription, the
DNA damage response, cell-cycle con-
trol, and apoptosis (reviewed in Sapountzi
et al., 2006). Strikingly, Terhune and
colleagues find that expression of Tat,
which can also destabilize Tip60 expres-
sion, can restore sensitivity to maribavir
of HCMV mutants lacking UL27 expres-
sion. This strongly argues that it is the
Tip60 degradation function of UL27 that
is crucial for its role in maribavir action.
The authors also find that expression of
UL27 induces heightened mRNA and
protein expression levels of the CDK
inhibitor protein p21Waf/CIP1, which was
attributed to loss of Tip60 expression.
Thus, in the context of HCMV infection,
Tip60 apparently plays a role in repres-
sing p21Waf/CIP1. The authors also used
shRNA to disrupt expression of another
putative UL27-interacting protein, the
ubiquitin-independent proteasome acti-
vator protein PSME3. This treatment,
too, caused elevated expression of
p21Waf/CIP1, which likewise restored mari-
bavir sensitivity to UL27 null HCMV. This
suggests that p21Waf/CIP1 is relevant to
UL27’s role in maribavir sensitivity.
The authors hypothesize (Figure 1) that
UL27 ordinarily acts to block cell-cycle
progression toward the G1/S phase
boundary. Specifically, they suggest
that UL27-mediated destruction of
Tip60 leads to enhanced expression of
p21Waf/CIP1, which can potently inhibit
cellular CDK activity, thus blocking cell-
cycle progression. In contrast, UL97
kinase activity, which is relatively insensi-
tive to p21Waf/CIP1, ordinarily promotes, February 17, 2011 ª2011 Elsevier Inc. 85
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Figure 1. Model for the Roles of UL27 and the Tip60 Histone Acetyltransferase in Human Cytomegalovirus Antiviral Drug Resistance
(A) UL27 promotes proteasome-dependent degradation of Tip60, leading to increased expression of p21Waf/CIP1 (p21), an inhibitor of cellular cyclin-dependent
kinase complexes (CDKs). Thus, in the presence ofmaribavir, an inhibitor of theUL97 protein kinase, wild-type human cytomegalovirus (HCMV) lacks any efficient
mechanism, cellular or viral, by which to inactivate the retinoblastoma tumor suppressor protein (Rb). Because active Rb represses cellular genes necessary for
cell-cycle progression and for viral DNA synthesis, wild-type HCMV replication is impaired in the presence of maribavir.
(B) UL27 null viruses are unable to promote degradation of Tip60. In the absence of Tip60 destruction, p21 expression remains low enough for cellular CDKs to
inactivate Rb, thus compensating for maribavir inhibition of UL97 activity and providing for resistance of UL27 mutant viruses to maribavir. In both (A) and (B),
active functions are shown as solid-bordered, colored shapes, while inactive functions are shown as dashed-bordered, gray shapes.
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in quiescent cells, by phosphorylation
and inactivation of Rb family members
(Hume et al., 2008; Kamil et al., 2009).
Therefore, when UL97 is inhibited by mar-
ibavir, increased levels of p21, such as
those induced by UL27-mediated
destruction of Tip60, would likely block
cellular CDK activity; Rb would remain
active, and S phase genes necessary for
viral DNA synthesis would remain silent.
Thus, the loss of UL27 would compensate
for the loss of UL97 function imposed by
maribavir, explaining the mechanism of
resistance.
Terhune and colleagues have made
considerable progress toward solving
the riddle of UL27 mutations in maribavir
resistance and in doing so have shed
new light on the biological function of
a mysterious viral gene. Nonetheless,
several matters merit further inquiry. First,
Tip60 degradation during wild-type
HCMV infection appears to be a transitory
phenomenon that does not correlate
neatly with UL27 expression (Reitsma
et al., 2011). UL27 is detectable starting
at 4–5 hpi, after which its expression
is relatively constant through at least
72 hpi. Tip60, however, is destabilized
as early as 2 hpi and undetectable at
6 hpi, and then its levels recover dramati-
cally by 24 hpi and appear to increase
further by 72 hpi. Why UL27 is capable
of degrading Tip60 at early but not late
times during infection is unclear. One
explanation would be that UL27’s func-
tion or substrate specificity is altered at86 Cell Host & Microbe 9, February 17, 2011later time points. It will be interesting
to determine whether UL27 becomes
posttranslationally modified as infection
proceeds. Regardless, UL27 affects the
impact ofmaribavir on viral DNA synthesis
and yield of infectious particles at up to 96
and 144 hpi, respectively, so how UL27’s
very early, apparently transitory effects on
Tip60 set the stage for later events
remains to be elucidated.
As mentioned above, MCMV M27 is
responsible for degradation of STAT2.
Thus, MCMV M27 and HCMV UL27
exhibit a conserved general function in
protein degradation, but have diverged
in their substrate specificity to target
distinct cellular factors for destruction.
Though their specificities do not seem to
overlap, one wonders whether either of
these two viral proteins targets any addi-
tional proteins for degradation. The func-
tion of the HCMV tegument protein
pp71 in protein degradation was originally
identified as targeting Rb family proteins,
but later was also found to be crucial
for destabilization of Daxx (reviewed in
Kalejta, 2008).
Since Reitsma et al. lean heavily on
the use of relatively high concentrations
of maribavir to inhibit UL97, it will be
important to confirm whether Tat and/or
p21 exacerbate the replication defective
phenotypes of UL97 null or UL97 kinase-
deficient HCMV mutants. Also, it remains
to be seen whether direct ectopic overex-
pression of p21Waf/CIP1 can restore mari-
bavir sensitivity to HCMV lacking UL27
expression. Notably, in HCMV-infectedª2011 Elsevier Inc.cells, p21Waf/CIP1 expression appears to
be regulated mainly by cathepsins rather
than by the proteasome, supporting the
notion that HCMV actively modifies the
expression of this molecule (Chen et al.,
2001). The mechanisms by which HCMV
orchestrates its regulation of p21Waf/CIP1
warrant further inquiry.
UL97 mimicry of CDKs is important not
only for viral DNA synthesis, but also plays
a role at the stage of nuclear egress,
where UL97 is required for disassembly
of the nuclear lamina, evidently by phos-
phorylating lamin A/C (Hamirally et al.,
2009). The effects of UL27 mutations
on maribavir inhibition of viral DNA
synthesis that Reitsma et al. observed
do not fully account for the correspond-
ing effects on yield of infectious virus.
Therefore, it would be worthwhile to
determine at which phase(s) UL27 arrests
cell-cycle progression and whether viral
nuclear egress and lamin A/C phosphory-
lation are enhanced during replication of
UL27 null viruses in the presence of
maribavir.
The literature implicates Tip60 in
processes as varied as chromatin regula-
tion, DNA repair, and apoptosis. More-
over, Tip60 is posited to play roles not
only as a HAT, but also in acetylation and
regulation of other biologically complex
transcriptional regulators, including p53
(reviewed in Kruse and Gu, 2009). Thus,
as is inevitable when a new function has
been identified, the work of Reitsma
et al. has opened the door for a plethora
of studies that are sure to tell us much
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cycle during infection. The study repre-
sents an excellent example of how using
drugs in the laboratory can be beneficial,
and it is not out of the question that its
results might have implications for the
use of such drugs in the clinic.ACKNOWLEDGMENTS
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Pioneering plant research has shown that many Nod-like receptors (NLRs) detect pathogens indirectly via
recognizing modifications of other host proteins. In this issue, two groups show that the RPM1 NLR is acti-
vated by phosphorylation of the host protein RIN4, probably resulting from activation of a host kinase by
pathogen effectors.The innate immune systems of both
plants and animals employ intracellular
receptors of the NOD-like receptor (NLR)
family to detect the presence of patho-
gens. NLRs are characterized by the
presence of a central nucleotide binding
and oligomerization domain (NOD, often
referred to as a NACHT or NB-ARC
domain) and C-terminal leucine-rich
repeats (LRRs). The N-terminal domains
are more variable, and differ between
plant and animal NLRs. The human
genome encodes 22 predicted functional
NLR genes (http://www.genenames.org/
genefamily/nlr.php), and mutations in
several of these have been linked to
multiple autoinflammatory and immuno-
deficiency diseases (Inohara et al., 2005;
Schroder and Tschopp, 2010). Under-
standing how NLR proteins are activated
is thus of intense interest to both plant
and animal immunologists.Work on plant NLR signaling pathways
is contributing to our understanding of
mammalian NLR signaling, particularly
in understanding how NLR proteins
‘‘detect’’ pathogens. Several plant NLRs
have been shown to detect pathogen
proteins indirectly via sensing pathogen-
induced modifications of other host
proteins (DeYoung and Innes, 2006).
This has raised the question of whether
mammalian NLRs might also use such
indirect recognition mechanisms. Recent
work indicates that human NLRP3, which
is activated by a diverse array of pathogen
molecules, probably detects the pres-
ence of pathogens indirectly (Schroder
and Tschopp, 2010). The common
denominator among the diverse signals
that activate NLRP3 appears to be excess
production of reactive oxygen species
(ROS) by mitochondria (Zhou et al.,
2011). Elevated levels of ROS appear tobe ‘‘sensed’’ by thioredoxin (TRX)-inter-
acting protein (TXNIP), which binds to
NLRP3 in a ROS-dependent manner
(Zhou et al., 2010). Thus, in this example,
pathogens and other cellular stresses
are being sensed indirectly by detecting
the presence of free TXNIP released
from thioredoxin as a consequence of
elevated ROS. Whether other mammalian
NLRs use such indirect mechanisms of
detection remain to be determined, but
this seems likely given the diversity of
activators for most characterized NLRs
and the complete absence of evidence
for direct binding of known activators to
their corresponding NLRs.
Among plant NLRs, arguably the best
characterized is the RPM1 protein of
Arabidopsis. RPM1 is activated by at least
two different effector proteins from Pseu-
domonas syringae, AvrB and AvrRpm1.
Activation of RPM1 by either of these, February 17, 2011 ª2011 Elsevier Inc. 87
